Drug intelligence / Profile preview

gonyautoxin 3

Development stage
Unknown
Lead developer
Algenis
Modality
Small Molecules
Administration
Intramuscular, Periarticular (local Injection)
01

Overview

**Gonyautoxin 3** is a naturally occurring marine toxin belonging to the group of paralytic shellfish poisons known as gonyautoxins, which are sulfated derivatives of saxitoxin. It functions as a highly selective **blocker of voltage-gated sodium channels** (VGSCs), inhibiting sodium ion influx in excitable cells and thereby preventing action potential propagation. This property leads to neuromuscular blockade and paralysis at sufficient concentrations. Gonyautoxin 3 is under investigation as an analgesic for acute pain, such as low back pain and for perioperative pain control after procedures like total knee arthroplasty. It is structurally classified as a small molecule, bis-guanidinium derivative, and is typically detected in the context of marine toxin monitoring. The compound is being developed as part of mixtures (notably with gonyautoxin 2) for clinical use.

Brand names
NAVX-010NAVX010NAVX 010
Other names
(+)-gonyautoxin 311β-hydroxysaxitoxin 11-sulfate1h,10h-pyrrolo(1,2-c)purine-9,10,10-triol 2,6-diamino-4-((aminocarbonyl)oxy)methyl-3a,4,8,9-tetrahydro-9-(hydrogen sulfate) 11-sulfate
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on gonyautoxin 3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gonyautoxin 3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call